1 |
Graphic representation of chemical formulae in the publications of international nonproprietary names (INN) for pharmaceutical substances, WHO/PHARM/95.579 (1997)
|
2 |
INNs for immunoglobulins, WHO/PharmS/Nom1517 (1995)
|
3 |
Pharmacological Action and Therapeutic Use of Drugs, list of terms, English/French/Spanish, PHARM/96.320 (1996)
|
4 |
International nonproprietary names (INN) for biological and biotechnological substances, INN Working Document05.179 (2006)
|
5 |
WHO Drug Information, Vol 19, 2 (2005)
|
6 |
약식심사발제 0331001호 규정, 일본후생노동성 (2006)
|
7 |
Guidelines on the use of International Nonproprietary Names (INNs) for pharmaceutical substances, WHO/PharmS/ Nom1570 (1997)
|
8 |
Boring, D. (1997). The development and adoption of nonproprietary, established, and proprietary names for pharmaceuticals. Drug Info J., 31, 621-634
DOI
|
9 |
The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, WHO/ EDM/QSM/2004.5 (2004)
|
10 |
INN nomenclature for peptides, glycopeptides, proteins and glycoproteins, WHO/PharmS/Nom1428 (1994)
|
11 |
'생명공학의약품의 국제일반명 설정에 관한 연구'(연구책임자 문애리), 식품의약품안전청 용역과제 최종보고서 (2006)
|
12 |
Pre-stems: suffixes used in the selection of INNs, INN Working Document 06.186/P (2006)
|
13 |
Consultation on International Nonproprietary Names (INN) and biological products, INN Working Document00.118 (2002)
|
14 |
International Nonproprietary Names: revised procedure, WHO/EB115/11 (2004)
|
15 |
INNs for biosynthetic vaccines, WHO/PharmS/Nom1419 (1994)
|
16 |
INNs for recombinant vaccines and viruses, WHO/PharmS/ Nom1719 (1998)
|